High-content oxytetracycline injection and preparation method thereof

A technology of oxytetracycline and injection, applied in the field of veterinary high-content oxytetracycline injection and preparation thereof, can solve the problem of producing precipitation, optimal use ratio not mentioned, no glycerol formal and dimethylacetamide Use ratio studies etc.

Pending Publication Date: 2020-04-21
北京喜禽药业有限公司 +1
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Chinese patents CN101966330A, CN101954084A, and CN101422479A all mentioned that glycerin formal and dimethylacetamide can be used as drug excipients in the three patents to improve drug stability, but the three did not treat glycerin formal and dimethylacetamide. In-depth research on the use ratio of amides, the optimal use ratio of the two excipients is not mentioned
The main reason is that it is easy to change color after long-term storage, or produce precipitation, and the stability is poor, resulting in the reduction of active ingredients and affecting its use effect
However, the 30% high content of oxytetracycline injection is even more difficult in terms of preparation process and product stability.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • High-content oxytetracycline injection and preparation method thereof
  • High-content oxytetracycline injection and preparation method thereof
  • High-content oxytetracycline injection and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] Example 1: Each 100ml of oxytetracycline injection contains 35g of oxytetracycline base, 2.4g of magnesium oxide, 1.0g of sodium formaldehyde sulfoxylate, 25g of glycerin formal, 40g of N,N-dimethylacetamide, monoethanolamine 1.6g, the rest is water for injection. (glycerol formal: dimethylacetamide is 2.5:4)

Embodiment 2

[0019] Example 2: Each 100ml of oxytetracycline injection contains 35g of oxytetracycline base, 2.4g of magnesium oxide, 1.0g of sodium formaldehyde sulfoxylate, 25g of glycerin formal, 35g of N,N-dimethylacetamide, monoethanolamine 1.6g, the rest is water for injection. (Glycerol formal: dimethylacetamide is 2.5:3.5)

Embodiment 3

[0020] Example 3: Each 100ml of oxytetracycline injection contains 35g of oxytetracycline base, 2.4g of magnesium oxide, 1.0g of sodium formaldehyde sulfoxylate, 25g of glycerin formal, 30g of N,N-dimethylacetamide, monoethanolamine 1.6g, the rest is water for injection. (glycerol formal: dimethylacetamide is 2.5:3)

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a high-content oxytetracycline injection and a preparation method thereof, belonging to the field of oxytetracycline injections for veterinary use. Every 100 mL of the oxytetracycline injection comprises 30 g to 35 g of oxytetracycline, 2.0 g to 3.0 g of magnesium oxide, 0.3 g to 1.0 g of sodium formaldehyde sulfoxylate, 20 g to 40 g of glycerolformal, 20 g to 40 g of N,N-dimethylacetamide, and 1.5 g to 2.0 g of monoethanolamine, with the balance being water for injection. The preparation method comprises the following steps: (1) adding a proper amount of water for injection to dissolve sodium formaldehyde sulfoxylate; (2) adding magnesium oxide and carrying out stirring to uniformly disperse the magnesium oxide; (3) continuing adding glycerolformal, N,N-dimethylacetamide and monoethanolamine; (4) introducing nitrogen, carrying out heating to 50-60 DEG C, adding oxytetracycline alkali, and carrying out stirring to dissolve the oxytetracycline alkali; (5) addingmonoethanolamine to adjust the pH value of the obtained solution to 8.4-8.7; and (6) supplementing water for injection until a volume is 100 mL. According to the invention, an optimal ratio is selected by screening the ratios of glycerolformal to dimethylacetamide; and it is verified that the oxytetracycline injection is good in stability, not prone to discoloring and content reduction after beingplaced for a long time, and free of sediments.

Description

technical field [0001] The invention belongs to the technical field of oxytetracycline injection for veterinary use, and in particular relates to a high-content oxytetracycline injection for veterinary use and a preparation method thereof. Background technique [0002] Oxytetracycline is a tetracycline antibiotic, which is a broad-spectrum antibiotic. It has a strong effect on Gram-positive bacteria such as Staphylococcus, hemolytic streptococcus, Bacillus anthracis, Clostridium tetani and Clostridium, and is also effective on Escherichia coli, Salmonella, Gram-negative bacteria such as Brucella and Pasteurella have good antibacterial activity. In addition, they also have inhibitory effects on Rickettsia, Chlamydia, Mycoplasma, Spirochetes, Actinomycetes and some protozoa. [0003] As the most widely used antibiotic in livestock and poultry and other animals, oxytetracycline is the basic medicine for livestock and poultry health care. It is mainly used for the treatment of r...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/08A61K47/02A61K47/20A61K47/18A61K47/22A61K31/65A61P31/04A61P33/02
CPCA61K9/08A61K9/0019A61K47/02A61K47/20A61K47/18A61K47/22A61K31/65A61P31/04A61P33/02
Inventor 李学良王心喜陈昌徐小斌王秀峰侯晓礁陈立红郭智伟王秀敏江厚生
Owner 北京喜禽药业有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products